相似文献
1
Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
Antimicrob Agents Chemother. 1995 Nov;39(11):2555-9. doi: 10.1128/AAC.39.11.2555.
2
Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
J Biol Chem. 1994 Apr 29;269(17):12633-8.
3
Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Res Virol. 1996 Mar-Jun;147(2-3):155-63. doi: 10.1016/0923-2516(96)80230-5.
4
Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
J Clin Invest. 1993 May;91(5):2326-33. doi: 10.1172/JCI116463.
5
6
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
J Exp Med. 1988 Sep 1;168(3):1111-25. doi: 10.1084/jem.168.3.1111.
7
Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.
Biochem Pharmacol. 1994 Oct 7;48(7):1477-81. doi: 10.1016/0006-2952(94)90573-8.
8
Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells.
Biochem Pharmacol. 1995 Jul 17;50(2):274-6. doi: 10.1016/0006-2952(95)00106-a.
9
Anti-HIV activity of novel phosphonate derivatives of AZT, d4T, and ddA.
Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):767-9. doi: 10.1081/NCN-100002426.
10
Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):296-302. doi: 10.1097/00042560-199804010-00002.
引用本文的文献
1
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold.
Antiviral Res. 2019 Feb;162:5-21. doi: 10.1016/j.antiviral.2018.11.016. Epub 2018 Dec 8.
2
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.
Antiviral Res. 2018 Jun;154:66-86. doi: 10.1016/j.antiviral.2018.04.004. Epub 2018 Apr 10.
3
The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue.
AIDS. 2018 Jan 2;32(1):11-15. doi: 10.1097/QAD.0000000000001678.
4
GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.
Antimicrob Agents Chemother. 2013 Dec;57(12):6110-21. doi: 10.1128/AAC.01420-13. Epub 2013 Sep 30.
5
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.
HIV Med. 2013 Aug;14(7):401-9. doi: 10.1111/hiv.12017. Epub 2013 Feb 24.
6
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.
HIV Seq Compend. 2001;2001:1-51.
7
Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):156-62. doi: 10.1097/QAI.0b013e31816de21e.
8
R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
J Virol. 2006 Jan;80(2):854-65. doi: 10.1128/JVI.80.2.854-865.2006.
9
Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.
Antimicrob Agents Chemother. 2004 Aug;48(8):2825-30. doi: 10.1128/AAC.48.8.2825-2830.2004.
10
A positively charged side chain at position 154 on the beta8-alphaE loop of HIV-1 RT is required for stable ternary complex formation.
Nucleic Acids Res. 2003 Sep 1;31(17):5167-74. doi: 10.1093/nar/gkg708.
本文引用的文献
1
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
Antimicrob Agents Chemother. 1993 Apr;37(4):810-7. doi: 10.1128/AAC.37.4.810.
2
Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
J Clin Invest. 1993 May;91(5):2326-33. doi: 10.1172/JCI116463.
3
Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):562-6. doi: 10.1073/pnas.90.2.562.
4
Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
J Biol Chem. 1994 Apr 29;269(17):12633-8.
5
Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phosphotriester and 3'-azido-2',3'-dideoxythymidine.
Biochem Pharmacol. 1994 Jul 5;48(1):11-14. doi: 10.1016/0006-2952(94)90217-8.
6
Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus.
Virology. 1981 Apr 15;110(1):202-7. doi: 10.1016/0042-6822(81)90022-2.
7
Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells.
Mol Pharmacol. 1989 Aug;36(2):291-5.
8
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
Science. 1986 Dec 19;234(4783):1563-6. doi: 10.1126/science.2431484.
9
Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.
Antimicrob Agents Chemother. 1990 Jun;34(6):1061-7. doi: 10.1128/AAC.34.6.1061.
10
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
Cell. 1990 Apr 20;61(2):213-22. doi: 10.1016/0092-8674(90)90802-l.
Zotero 插件